Related Experiment Video

Updated: May 2, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

29.3K

[Management of refractory neuroblastoma with high-dose topotecan plus cyclophosphamide and vincristine]

Jian Chang1, Yu-Tong Zhang, Li-Zhe Wang

  • 1Department of Pediatric Hematology and Oncology, First Hospital of Jilin University, Changchun, Jilin 130021, China.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|February 27, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

11.8K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

19.9K

Related Experiment Videos

Last Updated: May 2, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

29.3K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

11.8K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

19.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

820
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
820
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K

Articles linked to this work by shared authors, journal, and citation graph.

Comparative efficacy and safety of pharmacologic, laser, and combination therapies for infantile hemangioma: a systematic review and network meta-analysis with evidence certainty assessment.

Frontiers in pharmacology·2026

Efficacy and Safety of Jiannao Tongluo Granules in the Treatment of Convalescent Cerebral Infarction: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial.

Current medical science·2026

Multigene phylogeny and taxonomy of Hydnaceae (Cantharellales, Basidiomycota) reveal Leucopruina abieticola gen. et sp. nov. from Southwest China.

Frontiers in microbiology·2026

Exploring drug sensitivity guided individualized treatment in pediatric spindle cell/sclerosing rhabdomyosarcoma.

Frontiers in pharmacology·2026

Taxonomy and phylogeny of Dacrymyces (Dacrymycetales, Basidiomycota) with descriptions of a new species from China.

Frontiers in microbiology·2026

Predictive value of combined electrocardiographic and echocardiographic parameters for major adverse cardiovascular events in patients with established coronary artery disease: a single-center retrospective cohort study.

Frontiers in medicine·2026

[Research progress on the pathological mechanisms and clinical translation of ferroptosis in necrotizing enterocolitis].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

[Chemotherapy-related central nervous system injury in children with acute lymphoblastic leukemia: research progress].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

[Advances in the application of individualized white-matter functional networks in children and adolescents with attention-deficit/hyperactivity disorder].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

[Growth plate regulation and short stature: mechanistic insights and therapeutic advances].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

[Research progress on the microbiota-immune-metabolism axis in childhood obesity-related asthma].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

[Gambogic acid protects against lipopolysaccharide-induced acute lung injury via the MAPK signaling pathway].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

Integrated models of palliative medicine and pain management for the treatment of cancer-related pain: a review.

Current opinion in supportive and palliative care·2026

BRCAness-Driven Prognostic Model and Regimen-Specific Therapeutic Implications in Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.

International journal of cancer·2026

The allogeneic eDN70(-) CAR-T Cells Without TCR or MHC Editing Exhibit Enhanced Persistence and Function.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Presumed oxaliplatin-related Guillain-Barré syndrome: A case report and review of chemotherapy-related Guillain-Barré syndrome.

Medicine·2026

Retrospective observational study of transcatheter arterial chemoembolization (TACE) combined with PD-1 inhibitor and tyrosine kinase inhibitor (TKI) in advanced hepatocellular carcinoma.

Medicine·2026

Influenza A (H1N1) virus infection complicated by checkpoint inhibitor pneumonitis: A case report.

Medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us